돌아가기
Huagongshe화공사 화학 정보 인쇄 보고서 · 연구 참고용
HRID 2111513생성일: 2026년 10월 24일

Erythromycin → Erythromycin A enol ether

https://huagongshe.com/ko/reaction/2111513

반응식

참여 물질

역할이름HCID투입량
반응물ErythromycinHCID 12560—
반응물Sodium BicarbonateHCID 516892—
반응물Erythromycin - Impurity FHCID 9875064—
용매Acetic AcidHCID 176—
생성물Erythromycin A enol etherHCID 83954—

반응 단계

Synthesis of EM701 was disclosed in detail in WO 02/14338 A1. A glacial acetic acid solution of erythromycin was stirred at room temperature for 2 hours, and aqueous sodium hydrogencarbonate solution was slowly added and neutralized. The reaction mixture was extracted with chloroform. The organic layer was dehydrated by adding anhydrous sodium sulfate, which was removed off by filtration to obtain crude product. The crude product was purified by silica gel column chromatography with chloroform-methanol-aqueous ammonia (10:0.5:0.01→10:1:0.05) to obtain erythromycin A enol ether. Potassium carbonate was added to methanol solution of erythromycin A enol ether and refluxed for 2 hours. After solvent was removed, the residue was dissolved in aqueous sodium hydrogencarbonate and the mixture was extracted with chloroform. The extract was dehydrated with sodium sulfate, filtered and distilled off. The obtained crude product was purified by silica gel column chromatography with chloroform-methanol-aqueous ammonia (10:0.5:0.01→10:1:0.05) to obtain EM701 (white powder).

출처 및 근거

DOI10.6084/m9.figshare.5104873.v1
특허 번호US07521428B2
출처 데이터셋uspto-grants-2009_04
ORD IDord-20f04dbbc9e74f7280d839e3ca439e37
출처 메모uspto-grants-2009_04